BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND HIP1, ILWEQ, 3092, ENSG00000127946 AND Treatment
7 results:

  • 1. Prevalence of invasive cancer in a large general practice patient population in New Zealand.
    Kim DH; Chepulis L; Keenan R; Lao C; Hodgson F; Bullen C; Lawrenson R
    J Prim Health Care; 2020 Sep; 12(3):215-224. PubMed ID: 32988443
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Symptoms, clusters and quality of life prior to surgery for breast cancer.
    Denieffe S; Cowman S; Gooney M
    J Clin Nurs; 2014 Sep; 23(17-18):2491-502. PubMed ID: 24329603
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Paclitaxel-induced apoptosis is blocked by camptothecin in human breast and pancreatic cancer cells.
    Jeansonne DP; Koh GY; Zhang F; Kirk-Ballard H; Wolff L; Liu D; Eilertsen K; Liu Z
    Oncol Rep; 2011 May; 25(5):1473-80. PubMed ID: 21331447
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.
    Cuzick J; Sestak I; Baum M; Buzdar A; Howell A; Dowsett M; Forbes JF;
    Lancet Oncol; 2010 Dec; 11(12):1135-41. PubMed ID: 21087898
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.
    ; Forbes JF; Cuzick J; Buzdar A; Howell A; Tobias JS; Baum M
    Lancet Oncol; 2008 Jan; 9(1):45-53. PubMed ID: 18083636
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial.
    ; Buzdar A; Howell A; Cuzick J; Wale C; Distler W; Hoctin-Boes G; Houghton J; Locker GY; Nabholtz JM
    Lancet Oncol; 2006 Aug; 7(8):633-43. PubMed ID: 16887480
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.
    Bonneterre J; Buzdar A; Nabholtz JM; Robertson JF; Thürlimann B; von Euler M; Sahmoud T; Webster A; Steinberg M; ;
    Cancer; 2001 Nov; 92(9):2247-58. PubMed ID: 11745278
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.